Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Endometrial Hyperplasia

• Progesterone Therapeutic Regimen Plus Statins in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia
• A Behavioral Intervention to Promote Primary Prevention and Uterine Preservation in Premenopausal Women With Obesity and Endometrial Hyperplasia
• Primary Prevention and Uterine Preservation in Premenopausal Women With Obesity and Endometrial Hyperplasia
• Medroxyprogesterone Acetate Plus Atorvastatin in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia
• A Pilot Study on Fertility Conservative Treatment of Atypical Endometrial Hyperplasia in Singapore
• GnRHa + Letrozole vs Diane-35 + Metformin in Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia Patients
• Weight Management Plus LNG-IUS/Megestrol Acetate in Endometrial Atypical Hyperplasia
• Longitudinal Follow-up in Women With Endometrial Hyperplasia Without Atypia
• Loxenatide Plus LNG-IUS in Endometrial Atypical Hyperplasia
• Levonorgestrel-Releasing Intrauterine System (LNG-IUS) in the Management of Atypical Endometrial Hyperplasia
• Liraglutide Plus Megestrol Acetate in Endometrial Atypical Hyperplasia
• Metformin Plus Megestrol Acetate as a Fertility-sparing Treatment in Patients With Atypical Endometrial Hyperplasia
• Megestrol Acetate Plus Rosuvastatin in Young Women With Atypical Endometrial Hyperplasia
• LVN- IUS Versus Oral Megesterol Acetate in Treatment of Atypical Endometrial Hyperplasia
• Vaginal Micronized Progesterone Versus Levonorgestrel for Treatment of Non-atypical Endometrial Hyperplasia
• MPA Versus Dydrogesterone for Management of Endometrial Hyperplasia Without Atypia
• Megestrol Acetate With or Without Pterostilbene in Treating Patients With Endometrial Cancer Undergoing Hysterectomy
• Value of LNG-IUS as Fertility-preserving Treatment of EAH and EC
• Exemestane in Treating Patients With Complex Atypical Hyperplasia of the Endometrium/Endometrial Intraepithelial Neoplasia or Low Grade Endometrial Cancer
• Megestrol Acetate Plus LNG-IUS in Young Women With Endometrial Atypical Hyperplasia
• Surgicel® & Endometrial Ablation in the Management of Perimenpausal Heavy Menstrual Bleeding
• Vaginal Estrogens Comparative Trial on Pelvic Organ Prolapse Patients
• Apoptotic Signaling Pathways in Rats With Endometrial Hyperplasia
• Levonorgestrel-Releasing Intrauterine System With or Without Everolimus in Treating Patients With Atypical Hyperplasia or Stage IA Grade 1 Endometrial Cancer
• The Effect of Neoadjuvant DMPA on Glandular Cellularity in Women Awaiting Hysterectomy
• Megestrol Acetate or Levonorgestrel-Releasing Intrauterine System in Treating Patients With Atypical Endometrial Hyperplasia or Endometrial Cancer
• Improving the Treatment for Women With Early Stage Cancer of the Uterus
• Metformin for the Treatment of Endometrial Hyperplasia
• Efficacy of LNG-IUS for Treatment of Non-atypical Endometrial Hyperplasia in Perimenopausal Women
• A Study Comparing Mirena and Systemic Progestin for Endometrial Hyperplasia
• Efficacy and Tolerability Study of Progesterone Vaginal Tablets (Endometrin®) in Menopausal Women Treated by Estrogen
• Mirena Observational Program
• Study Evaluating Safety and Efficacy of Bazedoxifene/Conjugated Estrogens Combinations in Postmenopausal Women
• Megestrol in Treating Patients With Endometrial Neoplasia or Endometrial Hyperplasia
• Management of Atypical Endometrial Hyperplasia and Endometrial Carcinoma Using Megestrol Acetate
• Genistein and Endometrial Hyperplasia
• Study Evaluating Bazedoxifene/Conjugated Estrogens Combinations In Postmenopausal Women
• Surgery Plus Medroxyprogesterone in Preventing Endometrial Cancer
• Soy Estrogen Alternative Study (SEA)